Pharmacopoeia Commission for Indian Medicine
Source : PIB
GS II : Governance
What is discussed?
- About the Commission
- How it helps ?
Why in News ?
The Government of India has established Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H) as a subordinate office under Ministry of Ayush by merging Pharmacopoeia Commission of Indian Medicine & Homoeopathy (PCIM&H) and the two central laboratories namely
- Pharmacopoeia Laboratory for Indian Medicine (PLIM), Ghaziabad
- Homoeopathic Pharmacopoeia Laboratory (HPL)
Key Facts
Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H)
- The Commission is engaged in development of Pharmacopoial Standards for Ayurvedic, Unani, Siddha & Homoeopathic drugs.
- Also acting as Central Drug Testing cum Appellate Laboratory for Indian systems of Medicine & Homoeopathy.
- Pharmacopoeia is an officially recognized book of standards as per the Drugs and Cosmetics Act, 1940 and Rules 1945 there under.
- As per the Second Schedule of the Drugs and Cosmetics Act, it is designated as the official book of standards for drugs imported and/or manufactured for sale, stock or exhibition for sale or distribution in India.
- It specifies the standards of drugs manufactured and marketed in India in terms of their identity, purity and strength.
How this merger Helps?
- This will enhance the infrastructural facilities, technical manpower and financial resources these organisation.
- It will facilitate focused and cohesive development of standards of AYUSH drugs and publication of pharmacopoeias and formularies.
Current Status
- After re-establishment, a total of 1483 samples of ASU&H drugs have been tested during 6th July, 2020 to till date and 03 Pharmacopoeial monographs along with their formulary specifications for AYUSH Kwath related formulation has been published.
- Apart from Pharmacopoeial Monographs, National Formulary for Unani Medicines, Part-IV (2nd Edition) comprising formulary specifications of 166 formulations have also be published.
Daily Current Affairs : Click Here